FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor

被引：0
|
作者：
Asher Mullard
机构：
来源：
Nature Reviews Drug Discovery | 2023年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：173 / 173
相关论文
共 50 条
  • [1] FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor
    Mullard, Asher
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (03) : 173 - 173
  • [2] ROXADUSTAT Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor Treatment of Anemia
    Virgili-Lopez, G.
    [J]. DRUGS OF THE FUTURE, 2014, 39 (11) : 783 - 791
  • [3] Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease
    Kurata, Yu
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (04): : 414 - 422
  • [4] Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition
    Robinson, Andreas
    Keely, Simon
    Karhausen, Joern
    Gerich, Mark E.
    Furuta, Glenn T.
    Colgan, Sean P.
    [J]. GASTROENTEROLOGY, 2008, 134 (01) : 145 - 155
  • [5] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
    Ogawa, Chie
    Tsuchiya, Ken
    Maeda, Kunimi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [6] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD
    Parfrey, Patrick
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (25): : 2390 - 2391
  • [7] Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Renal Function in Patient with Heart Failure
    Imamura, Teruhiko
    Ueno, Yohei
    Kinugawa, Koichiro
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (12)
  • [8] Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
    Johnson, Haley N.
    Prasad-Reddy, Lalita
    [J]. ANNALS OF PHARMACOTHERAPY, 2024,
  • [9] Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Heart Failure with Preserved Ejection Fraction
    Imamura, Teruhiko
    Hori, Masakazu
    Tanaka, Shuhei
    Kinugawa, Koichiro
    [J]. MEDICINA-LITHUANIA, 2021, 57 (12):
  • [10] Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure
    Yazaki, Mayu
    Nabeta, Takeru
    Takigami, Yu
    Eda, Yuko
    Fujita, Teppei
    Iida, Yuichiro
    Ikeda, Yuki
    Ishii, Shunsuke
    Ako, Junya
    Feola, Mauro
    [J]. MEDICINA-LITHUANIA, 2024, 60 (01):
12345